Evidence map›Paper›PMID 29368614›Full record

ReviewRespiratory research2018

Molecular imaging of pulmonary diseases.

Julien Dimastromatteo, Eric J Charles, Victor E Laubach

Abstract readReview
In one paragraph

Review in Respiratory research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Revolutionizing diagnosis of pulmonaryFrontiers in microbiology · 2024
    Pooled it
  2. Imaging of dopamine transporters in Parkinson disease: a meta-analysis ofAnnals of clinical and translational neurology · 2020
    Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Artificial intelligence in functional imaging of the lung.The British journal of radiology · 2022
    Review
  9. Article
  10. Optical Biosensors for Virus Detection: Prospects for SARS-CoV-2/COVID-19.Chembiochem : a European journal of chemical biology · 2021
    Review
  11. Article
  12. Molecular Imaging of Pulmonary Inflammation and Infection.International journal of molecular sciences · 2020
    Review
  13. Review
  14. Review
  15. Role of medical and molecular imaging in COPD.Clinical and translational medicine · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Julien DimastromatteoDepartment of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA.
Eric J CharlesDepartment of Surgery, University of Virginia, P.O. Box 801359, Charlottesville, VA, 22908, USA.
Victor E LaubachDepartment of Surgery, University of Virginia, P.O. Box 801359, Charlottesville, VA, 22908, USA. laubach@virginia.edu.

Funding

Cardiovascular Surgery Training ProgramT32HL007849 · NHLBI · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI KRON, IRVING L., LAUBACH, VICTOR E · 1998 to 2025
$7.0M
Network for Cardiothoracic Surgical Investigations in Cardiovascular MedicineUM1HL088925 · NHLBI · UNIVERSITY OF VIRGINIA · PI BADHWAR, VINAY, KRON, IRVING L. · 2013 to 2025
$6.8M
Adenosine A2 Receptors and Imaging of Inflammation in Lung Reperfusion InjuryR01HL130053 · NHLBI · UNIVERSITY OF VIRGINIA · PI KRON, IRVING L., LAUBACH, VICTOR E · 2017 to 2020
$2.6M
NHLBI NIH HHS R01 HL130053NHLBI NIH HHS T32 HL007849NHLBI NIH HHS T32HL007849NHLBI NIH HHS UM1 HL088925NHLBI NIH HHS UM1HL088925
6 · The paper itself

Abstract

Imaging holds an important role in the diagnosis of lung diseases. Along with clinical tests, noninvasive imaging techniques provide complementary and valuable information that enables a complete differential diagnosis. Various novel molecular imaging tools are currently under investigation aimed toward achieving a better understanding of lung disease physiopathology as well as early detection and accurate diagnosis leading to targeted treatment. Recent research on molecular imaging methods that may permit differentiation of the cellular and molecular components of pulmonary disease and monitoring of immune activation are detailed in this review. The application of molecular imaging to lung disease is currently in its early stage, especially compared to other organs or tissues, but future studies will undoubtedly reveal useful pulmonary imaging probes and imaging modalities.

Indexed as

Diagnosis, DifferentialGraft RejectionHumansLung DiseasesLung NeoplasmsMolecular ImagingMolecular imagingPETPulmonary diseaseSPECT

Identifiers

PMID29368614
PMCPMC5784614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.